Actavis Mid-Atlantic LLC clinical trials
Acquired by Teva Pharmaceutical Industries, Ltd., Aug 2, 2016 · source ↗
The registry lists 4 studies whose lead sponsor is Actavis Mid-Atlantic LLC. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Dec 30, 2011.
- 4studies on the registry
- 0open to participants now
Before and after it joined Teva Pharmaceutical Industries, Ltd.
- First submitted before Actavis Mid-Atlantic LLC became part of Teva Pharmaceutical Industries, Ltd.
- 4
- First submitted after Actavis Mid-Atlantic LLC became part of Teva Pharmaceutical Industries, Ltd.
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
What it is testing
The drugs Actavis Mid-Atlantic LLC’s studies test, most studies first; none is open now — 1 drug with a page of their own. Each count opens the studies in search.
Studies, none open
- 0 open · 2
All 4 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
- Completed4100%
Over the years
- 09
- 10
- 211
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 026
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
- Actavis Mid-Atlantic LLC4 studies
Something wrong with this grouping? Tell us on the Teva Pharmaceutical Industries, Ltd. page.
Studies
Recruiting first, then most recently updated. Showing 4 of 4. All Teva Pharmaceutical Industries, Ltd. studies →
- A Bioequivalence Study With Clinical Endpoints Comparing Generic Imiquimod Cream, 3.75% and Zyclara™ (Imiquimod) Cream, 3.75% in Subjects With Actinic KeratosesCompletedNCT01502020Not applicable
Sponsor listed in the registry: Actavis Mid-Atlantic LLC · First submitted before Actavis Mid-Atlantic LLC became part of Teva Pharmaceutical Industries, Ltd.
- A Bioequivalence Study With Clinical Endpoints Comparing Adapalene and Benzoyl Peroxide Topical Gel 0.1%/2.5% (Actavis Mid-Atlantic LLC) To Epiduo™ (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% (Galderma Laboratories, L.P.) in the Treatment of Mild to Severe Acne VulgarisCompletedNCT01501799Not applicable
Sponsor listed in the registry: Actavis Mid-Atlantic LLC · First submitted before Actavis Mid-Atlantic LLC became part of Teva Pharmaceutical Industries, Ltd.
- Bioequivalence Study Comparing Clindamycin Phosphate (1.2%) and Tretinoin (0.025%) Topical Gel to Ziana and PlaceboCompletedNCT01257906Not applicable
Sponsor listed in the registry: Actavis Mid-Atlantic LLC · First submitted before Actavis Mid-Atlantic LLC became part of Teva Pharmaceutical Industries, Ltd.
- Study Comparing 0.3% Adapalene Topical Gel to Differin® 0.3% Adapalene Topical GelCompletedNCT01095640Not applicable
Sponsor listed in the registry: Actavis Mid-Atlantic LLC · First submitted before Actavis Mid-Atlantic LLC became part of Teva Pharmaceutical Industries, Ltd.